Axitinib
targeted anticancer therapy · kinase inhibitor
Nothing to addWhat this medicine is for
Pharmacologically, Axitinib relates to the category “targeted anticancer therapy (kinase inhibitor)”. This targeted therapy attacks a specific mechanism of tumor cells; it falls under a specialized hospital prescription.
Specifically, for Axitinib: Treats a cancer by targeting tumor cells. It is part of specialized, closely monitored care.
Under which brands it is found
In France, about 5 reimbursable presentations containing Axitinib are recorded. It comes under various trade names and in generic form.
- Axitinib Biogaran
- Axitinib Eg
- Axitinib Sandoz
- Axitinib Teva
- Inlyta
Generics and the original brand are equivalent for the active substance; only the appearance, the name or the excipients may differ.
Do you need a supplement? No.
We put forward no supplement for Axitinib: that would be forcing a need that does not exist. The great majority of medicines call for no particular supplementation, and acknowledging this is part of the way we work. We design a supplement only where the data support it, across five specific classes.
Talk about it in the community
A space to share among people who are affected: the early days, the habits built up over the years, what each person has found to live better with it. Shared experiences, nothing medical.
Related molecules
To explore in the « Other areas » family and its neighbours.